Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Sonraí bibleagrafaíochta
Príomhchruthaitheoir: Flora, Sanzida Alam
Rannpháirtithe: Azam, Faruque
Formáid: Tráchtas
Teanga:English
Foilsithe / Cruthaithe: Brac University 2024
Ábhair:
NSCLC
Tyrosine kinase inhibitor
Efficacy endpoints
Cancer therapy
Lung cancer
Lung cancer > Treatment
Protein-tyrosine kinase > Inhibitors > Therapeutic use
Rochtain ar líne:http://hdl.handle.net/10361/23693

Ar líne

http://hdl.handle.net/10361/23693

Míreanna comhchosúla